173 related articles for article (PubMed ID: 18697946)
1. The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles.
Dai S; Crawford F; Marrack P; Kappler JW
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11893-7. PubMed ID: 18697946
[TBL] [Abstract][Full Text] [Related]
2. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.
Nielsen M; Lundegaard C; Blicher T; Peters B; Sette A; Justesen S; Buus S; Lund O
PLoS Comput Biol; 2008 Jul; 4(7):e1000107. PubMed ID: 18604266
[TBL] [Abstract][Full Text] [Related]
3. Complementarity and redundancy of the binding specificity of HLA-DRB1, -DRB3, -DRB4 and -DRB5 molecules.
Texier C; Pouvelle-Moratille S; Busson M; Charron D; Ménez A; Maillère B
Eur J Immunol; 2001 Jun; 31(6):1837-46. PubMed ID: 11433380
[TBL] [Abstract][Full Text] [Related]
4. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
5. A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.
Mellins E; Cameron P; Amaya M; Goodman S; Pious D; Smith L; Arp B
J Exp Med; 1994 Feb; 179(2):541-9. PubMed ID: 8294865
[TBL] [Abstract][Full Text] [Related]
6. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
[TBL] [Abstract][Full Text] [Related]
7. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
[TBL] [Abstract][Full Text] [Related]
8. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
Painter CA; Stern LJ
Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic structure of the human leukocyte antigen DRA, DRB3*0101: models of a directional alloimmune response and autoimmunity.
Parry CS; Gorski J; Stern LJ
J Mol Biol; 2007 Aug; 371(2):435-46. PubMed ID: 17583734
[TBL] [Abstract][Full Text] [Related]
10. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule.
Weyand CM; Hicok KC; Hunder GG; Goronzy JJ
J Clin Invest; 1992 Dec; 90(6):2355-61. PubMed ID: 1469092
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes.
Fisher M; Pusey CD; Vaughan RW; Rees AJ
Kidney Int; 1997 Jan; 51(1):222-9. PubMed ID: 8995737
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR polymorphism affects the interaction with CD4.
Fleury S; Thibodeau J; Croteau G; Labrecque N; Aronson HE; Cantin C; Long EO; Sékaly RP
J Exp Med; 1995 Sep; 182(3):733-41. PubMed ID: 7650480
[TBL] [Abstract][Full Text] [Related]
13. A novel family of human leukocyte antigen class II receptors may have its origin in archaic human species.
Temme S; Zacharias M; Neumann J; Wohlfromm S; König A; Temme N; Springer S; Trowsdale J; Koch N
J Biol Chem; 2014 Jan; 289(2):639-53. PubMed ID: 24214983
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR beta chain residue 86 controls DR alpha beta dimer stability.
Verreck FA; Termijtelen A; Koning F
Eur J Immunol; 1993 Jun; 23(6):1346-50. PubMed ID: 8500529
[TBL] [Abstract][Full Text] [Related]
15. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
Ovsyannikova IG; Vierkant RA; Poland GA
Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific variation in the degeneracy of major histocompatibility complex (MHC) restriction.
Carmichael P; Copier J; So A; Lechler R
Hum Immunol; 1997 Apr; 54(1):21-9. PubMed ID: 9154454
[TBL] [Abstract][Full Text] [Related]
17. Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Chang JW; Mechling DE; Bächinger HP; Burrows GG
J Biol Chem; 2001 Jun; 276(26):24170-6. PubMed ID: 11319230
[TBL] [Abstract][Full Text] [Related]
18. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.
Hammer J; Valsasnini P; Tolba K; Bolin D; Higelin J; Takacs B; Sinigaglia F
Cell; 1993 Jul; 74(1):197-203. PubMed ID: 8334703
[TBL] [Abstract][Full Text] [Related]
19. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of the serological DR LYGUE and genotypic DRB1*1303 specificities using a tetanus toxin-specific T-cell clone.
Martínez-Soria E; Tiercy JM; Beffy P; Taban-Marín P; Jaques D; Bétuel H; Jeannet M; Mach B; Irlé C
Tissue Antigens; 1993 Sep; 42(3):118-24. PubMed ID: 8284784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
